These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2735961)
1. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Wallace CA; Bleyer WA; Sherry DD; Salmonson KL; Wedgwood RJ Arthritis Rheum; 1989 Jun; 32(6):677-81. PubMed ID: 2735961 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. Ravelli A; Di Fuccia G; Molinaro M; Ramenghi B; Zonta L; Regazzi MB; Martini A J Rheumatol; 1993 Sep; 20(9):1573-7. PubMed ID: 8164218 [TBL] [Abstract][Full Text] [Related]
3. Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate. Rose CD; Fawcett PT; Gibney K; Doughty RA; Singsen BH Ann Rheum Dis; 1994 Jul; 53(7):471-4. PubMed ID: 7944621 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis. Lin YT; Tsai MJ; Wang LH; Huang MT; Yang YH; Chiang BL J Formos Med Assoc; 2000 Aug; 99(8):623-9. PubMed ID: 10969505 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy in systemic-onset juvenile rheumatoid arthritis in Saudi Arabia: a retrospective analysis. al-Sewairy W; al-Mazyed A; al-Dalaan ; al-Balaa S; Bahabri S Clin Rheumatol; 1998; 17(1):52-7. PubMed ID: 9586680 [TBL] [Abstract][Full Text] [Related]
7. Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics. Albertioni F; Flatø B; Seideman P; Beck O; Vinje O; Peterson C; Eksborg S Eur J Clin Pharmacol; 1995; 47(6):507-11. PubMed ID: 7768253 [TBL] [Abstract][Full Text] [Related]
8. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Reiff A; Shaham B; Wood BP; Bernstein BH; Stanley P; Szer IS Clin Exp Rheumatol; 1995; 13(1):113-8. PubMed ID: 7774090 [TBL] [Abstract][Full Text] [Related]
9. Measuring transaminases in patients with rheumatoid arthritis on weekly methotrexate: does timing of blood testing matter? Mecoli CA; Delev NG; Bingham CO Clin Rheumatol; 2016 Dec; 35(12):3053-3056. PubMed ID: 27473088 [TBL] [Abstract][Full Text] [Related]
10. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH Arthritis Rheum; 1997 Dec; 40(12):2226-34. PubMed ID: 9416861 [TBL] [Abstract][Full Text] [Related]
11. Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis. Gottlieb BS; Keenan GF; Lu T; Ilowite NT Pediatrics; 1997 Dec; 100(6):994-7. PubMed ID: 9374571 [TBL] [Abstract][Full Text] [Related]
12. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. Wallace CA; Sherry DD; Mellins ED; Aiken RP J Rheumatol; 1993 Jan; 20(1):118-22. PubMed ID: 8441141 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate]. Gao JS; Wu H; Tian J Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):435-8. PubMed ID: 14748999 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Foell D; Frosch M; Schulze zur Wiesch A; Vogl T; Sorg C; Roth J Ann Rheum Dis; 2004 Feb; 63(2):206-8. PubMed ID: 14722212 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Ravelli A; Migliavacca D; Viola S; Ruperto N; Pistorio A; Martini A Clin Exp Rheumatol; 1999; 17(5):625-7. PubMed ID: 10544851 [TBL] [Abstract][Full Text] [Related]
16. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis. Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A; Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217 [TBL] [Abstract][Full Text] [Related]
18. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. Ravelli A; Gerloni V; Corona F; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano CG; Alessio M; Fantini F; Bardare M; Martini A Clin Exp Rheumatol; 1998; 16(2):181-3. PubMed ID: 9536397 [TBL] [Abstract][Full Text] [Related]